Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miko Yamada

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2018
Using elongated microparticles to enhance tailorable nanoemulsion delivery in excised human skin and volunteersMiko Yamada, Hossam Tayeb, Hequn Wang, et al.
Journal of Visualized Experiments : Jove|March 12, 2019
Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin AnalysisBenson U W Lei, Miko Yamada, Van L T Hoang, et al.
Vaccine|August 23, 2015
Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by ForodermPenny A Rudd, Anthony P Raphael, Miko Yamada, et al.
Contemporary Clinical Trials Communications|August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patientsMiko Yamada, Dennis M Miller, Melinda Lowe, et al.
Pigment Cell & Melanoma Research|May 12, 2016
Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformationCarly Fox, Duncan Lambie, James S Wilmott, et al.
Scientific Reports|November 30, 2019
Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stageZewen K Tuong, Andrew Lewandowski, Jennifer A Bridge, et al.
Neurosurgery|May 10, 2019
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent GliomasChirag G Patil, David G Walker, Dennis M Miller, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2018
Using elongated microparticles to enhance tailorable nanoemulsion delivery in excised human skin and volunteersMiko Yamada, Hossam Tayeb, Hequn Wang, et al.
Journal of Visualized Experiments : Jove|March 12, 2019
Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin AnalysisBenson U W Lei, Miko Yamada, Van L T Hoang, et al.
Vaccine|August 23, 2015
Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by ForodermPenny A Rudd, Anthony P Raphael, Miko Yamada, et al.
Contemporary Clinical Trials Communications|August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patientsMiko Yamada, Dennis M Miller, Melinda Lowe, et al.
Pigment Cell & Melanoma Research|May 12, 2016
Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformationCarly Fox, Duncan Lambie, James S Wilmott, et al.
Scientific Reports|November 30, 2019
Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stageZewen K Tuong, Andrew Lewandowski, Jennifer A Bridge, et al.
Neurosurgery|May 10, 2019
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent GliomasChirag G Patil, David G Walker, Dennis M Miller, et al.
Pageof 3